123 related articles for article (PubMed ID: 8469402)
1. MPTP neurotoxicity to cerebellar Purkinje cells in mice.
Takada M; Sugimoto T; Hattori T
Neurosci Lett; 1993 Feb; 150(1):49-52. PubMed ID: 8469402
[TBL] [Abstract][Full Text] [Related]
2. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Gaál J; Solti M; Kollár E; Singer J
J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228
[TBL] [Abstract][Full Text] [Related]
4. c-fos mRNA in mouse brain after MPTP treatment.
Duchemin AM; Gudehithlu KP; Neff NH; Hadjiconstantinou M
Neurochem Int; 1992 Apr; 20(3):281-7. PubMed ID: 1284678
[TBL] [Abstract][Full Text] [Related]
5. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
6. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
8. Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices.
Pai KS; Ravindranath V
Brain Res; 1991 Aug; 555(2):239-44. PubMed ID: 1933335
[TBL] [Abstract][Full Text] [Related]
9. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
10. The effects of monoamine oxidase inhibition and dopamine uptake blockade on MPTP-induced increase of 2-[3H]deoxyglucose uptake in specific mesencephalic catecholaminergic nuclei.
Hess A
Neurosci Lett; 1990 Apr; 112(1):7-13. PubMed ID: 2143566
[TBL] [Abstract][Full Text] [Related]
11. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
[TBL] [Abstract][Full Text] [Related]
12. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain.
Chan P; Di Monte DA; Langston JW
Brain Res; 1994 Jun; 647(2):249-54. PubMed ID: 7922501
[TBL] [Abstract][Full Text] [Related]
13. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
Ricaurte GA; Langston JW; DeLanney LE; Irwin I; Brooks JD
Neurosci Lett; 1985 Sep; 59(3):259-64. PubMed ID: 3932903
[TBL] [Abstract][Full Text] [Related]
14. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
[TBL] [Abstract][Full Text] [Related]
15. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Cohen G; Mytilineou C
Life Sci; 1985 Jan; 36(3):237-42. PubMed ID: 3917526
[TBL] [Abstract][Full Text] [Related]
17. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
18. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
Heikkila RE; Duvoisin RC; Finberg JP; Youdim MB
Eur J Pharmacol; 1985 Oct; 116(3):313-7. PubMed ID: 3935467
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Dluzen D; Jain R; Liu B
J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
